OverviewChartNewsTraderScreen

Soc. Generale Knock-Out Novo-Nord.../  DE000SW88RV6  /

Frankfurt Zert./SG
6/13/2024  11:55:20 AM Chg.+0.200 Bid6/13/2024 Ask6/13/2024 Underlying Strike price Expiration date Option type
9.800EUR +2.08% 9.800
Bid Size: 1,000		 10.000
Ask Size: 1,000		 - - DKK 9/20/2024 Call
GlobeNewswire 12:00 PM Biosplice Announces Collaboration with Novo Nordisk in Diabetes
GlobeNewswire 6/11 Biora Therapeutics Announces Presentation on the BioJet™ Systemic Oral Delivery Platform at the Next...
GlobeNewswire 6/10 RenovoRx Appoints Ryan Witt as Senior Vice President, Head of Corporate Strategy and Partnerships
GlobeNewswire 6/10 Veru to Present at the American Diabetes Association's 84th Scientific Sessions
GlobeNewswire 6/3 Aeterna Zentaris and Ceapro Complete Merger Transaction
GlobeNewswire 6/3 Aeterna Zentaris and Ceapro Complete Merger Transaction
GlobeNewswire 5/31 Zealand Pharma announces positive CHMP opinion for dasiglucagon for treatment of severe hypoglycemia...
GlobeNewswire 5/30 Anaqua Annual User Experience Conference to Feature Keynotes from Microsoft, SAP, USPTO, and More
GlobeNewswire 5/22 Veru to Present at the Jefferies Global Healthcare Conference
GlobeNewswire 5/15 Veru Announces Steven B. Heymsfield M.D. as the Principal Investigator for its Enobosarm Phase 2b Cl...
GlobeNewswire 5/15 Aeterna Zentaris Reports First Quarter 2024 Financial Results
GlobeNewswire 5/14 Veru Announces Mitchell Steiner as Keynote Speaker at Biomed Israel 2024: The 22nd National Life Sci...
GlobeNewswire 5/9 US Neurologists Report Route of Administration as a Critical Factor when Evaluating Future Parkinson...
GlobeNewswire 5/7 Vect-Horus to Take Part in a Roundtable Discussion at Viva Technology Conference
TeleTrader 4/25 Europe opens mostly down after corporate earnings
GlobeNewswire 4/22 Vect-Horus Publication in Pharmaceutics Outlines How Vectors Can Improve Delivery of Therapeutics to...
GlobeNewswire 4/22 SNIPR Biome receives funding from CARB-X to support advancement of CRISPR-medicine SNIPR001 into cli...
GlobeNewswire 4/22 SNIPR Biome receives funding from CARB-X to support advancement of CRISPR-medicine SNIPR001 into cli...
GlobeNewswire 4/11 Robbins LLP is Investigating the Acquisition of Catalent, Inc. (CTLT) by Novo Holdings
GlobeNewswire 4/2 Arch Biopartners Adds Three New Clinical Sites into the Phase II Trial for LSALT Peptide Targeting C...
GlobeNewswire 4/2 Avalo Therapeutics Appoints Biotech Leaders to Board of Directors
GlobeNewswire 3/28 Omega Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Strategi...
GlobeNewswire 3/27 Aeterna Zentaris Reports Fourth Quarter and Full Year 2023 Financial Results and Announces Completio...
GlobeNewswire 3/25 Tonix Pharmaceuticals Receives Rare Pediatric Disease Designation from the FDA for TNX-2900 for the ...
GlobeNewswire 3/18 Arch Biopartners Clinical Team Publishes Data from Phase II Trial for LSALT Peptide Targeting Organ ...